Filing Details

Accession Number:
0001209191-23-029760
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-16 16:05:20
Reporting Period:
2023-05-12
Accepted Time:
2023-05-16 16:05:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509463 A. Michael Sherman 2505 Meridian Parkway, Suite 100
Durham NC 27713
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-12 11,985 $1.13 11,985 No 4 P Indirect By Michael A Sherman Trust Dated June 29, 2007
Common Stock Acquisiton 2023-05-12 75,015 $1.12 87,000 No 4 P Indirect By Michael A Sherman Trust Dated June 29, 2007
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Michael A Sherman Trust Dated June 29, 2007
No 4 P Indirect By Michael A Sherman Trust Dated June 29, 2007
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 102,995 Indirect By Sherman Investors LLC
Common Stock 233,413 Direct
Footnotes
  1. Includes 10,418 shares acquired under the Issuer's Employee Stock Purchase Plan on March 10, 2023.
  2. The 233,413 shares includes, 92,950 restricted stock unit awards ("RSUs") that were granted on January 17, 2023, of which 23,237 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 23,237 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 23,237 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 23,239 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.